Livforsakringsbolaget Skandia, Omsesidigt Bristol Myers Squibb CO Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 17,232 shares of BMY stock, worth $1.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

17,232

Previous 3,568 382.96%

Holding current value

$1.01 Million

Previous $148,000 502.03%

% of portfolio

0.05%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$39.66 - $51.75 $541,914 - $707,112	13,664 Added 382.96%	17,232 $891,000
Q2 2024 Jul 15, 2024	SELL	$40.25 - $52.99 $4.17 Million - $5.48 Million	-103,500 Reduced 96.67%	3,568 $148,000
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $95,117 - $113,501	1,962 Added 1.87%	107,068 $5.49 Million
Q3 2023 Oct 20, 2023	SELL	$57.89 - $64.73 $277,872 - $310,704	-4,800 Reduced 4.37%	105,106 $6.1 Million
Q2 2023 Jul 06, 2023	SELL	$63.71 - $70.74 $700,810 - $778,140	-11,000 Reduced 9.1%	109,906 $7.03 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $3,549 - $2.1 Million	-27,300 Reduced 18.42%	120,906 $8.6 Million
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $544,650 - $599,850	-7,500 Reduced 4.82%	148,206 $11.4 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $595,293 - $693,972	-11,100 Reduced 6.65%	155,706 $9.71 Million
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $680,455 - $797,065	11,500 Added 7.4%	166,806 $9.87 Million
Q2 2021 Jul 13, 2021	BUY	$61.91 - $67.42 $841,976 - $916,912	13,600 Added 9.6%	155,306 $10.4 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $1 Million - $1.13 Million	16,900 Added 13.54%	141,706 $8.95 Million
Q4 2020 Mar 02, 2021	BUY	$57.74 - $65.43 $536,982 - $608,499	9,300 Added 8.05%	124,806 $7.74 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $91,888 - $101,824	1,600 Added 1.4%	115,506 $6.96 Million
Q2 2020 Jul 08, 2020	BUY	$54.82 - $64.09 $21,928 - $25,636	400 Added 0.35%	113,906 $6.7 Million
Q1 2020 Apr 22, 2020	BUY	$46.4 - $67.43 $2.79 Million - $4.05 Million	60,100 Added 112.53%	113,506 $6.33 Million
Q4 2019 Jan 28, 2020	SELL	$49.21 - $64.19 $137,788 - $179,732	-2,800 Reduced 4.98%	53,406 $3.43 Million
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $29,939 - $35,497	700 Added 1.26%	56,206 $2.85 Million
Q2 2019 Jul 19, 2019	BUY	$44.62 - $49.34 $89,240 - $98,680	2,000 Added 3.74%	55,506 $2.52 Million
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $924,960 - $1.1 Million	-20,500 Reduced 27.7%	53,506 $2.55 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $2.27 Million - $2.95 Million	46,600 Added 170.04%	74,006 $3.85 Million
Q3 2018 Oct 26, 2018	SELL	$55.19 - $62.25 $932,711 - $1.05 Million	-16,900 Reduced 38.14%	27,406 $1.7 Million
Q2 2018 Jul 10, 2018	BUY	$50.53 - $62.98 $202,120 - $251,920	4,000 Added 9.92%	44,306 $2.45 Million
Q4 2017 Jan 18, 2018	SELL	$59.94 - $65.35 $953,046 - $1.04 Million	-15,900 Reduced 28.29%	40,306 $2.47 Million
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $3.1 Million - $3.58 Million	56,206	56,206 $3.58 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Bristol Myers Squibb CO Transaction History